Page 1 of Clinical Trials for Phase I-II, 219 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Withdrawn
Phase I-II for Patients With Recurrent or Refractory Non-small Cell Lung Cancer (NSCLC)
Last Updated: February 7, 2012
Condition(s): Lung Cancer
2
Completed
Study of Capecitabine and Oxaliplatin in Combination With Radiotherapy in Patients With Unresectable Gastro-Intestinal Cancer
Last Updated: October 14, 2011
Condition(s): Stomach Cancer; Gall Bladder Cancer; Bile Ductus Cancer; Pancreas Cancer; Colorectal Cancer
3
Not yet recruiting
Phase I-II Everolimus and Sorafenib in Recurrent High-Grade Gliomas
Last Updated: February 1, 2012
Condition(s): Brain Neoplasms; Central Nervous System Neoplasms
4
Recruiting
Phase I-II Trial of Sorafenib in Combination With Ifosfamide in Soft Tissue Sarcoma
Last Updated: May 8, 2008
Condition(s): Soft Tissue Sarcoma
5
Completed
Phase I-II Study of Carboplatin, Vinorelbine and Capecitabine in Patients With Metastatic Breast Cancer
Last Updated: January 6, 2010
Condition(s): Breast; Cancer
6
Completed
Phase I-II Study of Idarubicin, Cytarabine, and Sorafenib (BAY43-9006)
Last Updated: April 16, 2012
Condition(s): AML; Acute Myeloid Leukemia; Myelodysplastic Disorders
7
Completed
Retrospective Safety Survey In Patients Included In NV1FGF Clinical Trials
Last Updated: April 27, 2011
Condition(s): Peripheral Arterial Occlusive Disease
8
Completed
A Phase I - II Safety Study of Filgrastim (Neupogen) to Improve Left Ventricular Function After Severe Acute Myocardial Infarction
Last Updated: September 17, 2008
Condition(s): Acute Myocardial Infarction
9
Recruiting
Phase I-II to Evaluate Efficacy/Safety of Sorafenib+Gemcitabine+Radiotherapy in Locally Advanced Pancreatic Carcinoma
Last Updated: November 12, 2008
Condition(s): Pancreatic Cancer
10
Active, not recruiting
Navelbine, Taxol, Herceptin and Neupogen in Stage IV Breast Cancer: A Phase I - II Trial
Last Updated: February 20, 2008
Condition(s): Breast Cancer
11
Completed
Phase I-II Multiple-Dose Safety and Efficacy Study of a Selective Inhibitor of Cyclooxygenase - 2 (SC-58635) in Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Patients and Carriers
Last Updated: March 3, 2008
Condition(s): Colorectal Neoplasm; Hereditary Nonpolyposis
12
Completed
A Multicentre Phase I-II Study to Investigate the Combination of Bendamustine With Weekly Paclitaxel as First or Second Line Therapy in Patients With Metastatic Breast Cancer
Last Updated: August 31, 2011
Condition(s): Metastatic Breast Cancer
13
Completed
Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, Rituximab Pateinets With Aggresive NHL
Last Updated: February 3, 2012
Condition(s): Lymphoma; Non Hodgkin's Lymphoma
14
Completed
Study of Combination Immunotherapy for the Generation of HER-2/Neu Specific Cytotoxic T Cells
Last Updated: September 20, 2010
Condition(s): Breast Cancer
15
Completed
A Trial to Determine Radiation Exposure to Organs and Assess the Safety of CARDIOLITE® in Pediatric Subjects
Last Updated: June 1, 2011
Condition(s): Kawasaki Disease
16
Recruiting
A Trial of Capecitabine (Xeloda), Oxaliplatin and Irinotecan in Combination With Bevacizumab in 1st Line Treatment of Metastatic Colorectal Cancer
Last Updated: December 11, 2011
Condition(s): Metastatic Colorectal Cancer
17
Not yet recruiting
Pharmacokinetics and Safety of Meropenem in Infants Below 90 Days of Age With Probable and Confirmed Meningitis
Last Updated: March 13, 2012
Condition(s): Meningitis
18
Completed
Gemcitabine, Oxaliplatin and Capecitabine in Patients With Advanced Cholangiocarcinoma
Last Updated: August 25, 2008
Condition(s): Cholangiocarcinoma
19
Recruiting
Chlorambucil + Lenalidomide and Lenalidomide Maintenance in Untreated Elderly With Chronic Lymphocytic Leukemia (CLL)
Last Updated: November 7, 2011
Condition(s): Chronic Lymphocytic Leukemia
20
Active, not recruiting
MnSOD (Esophageal Protectant) to Prevent Esophagitis During Radiation/Chemotherapy Treatment for Non-Small Cell Lung Cancer (NSCLC)
Last Updated: January 6, 2012
Condition(s): Radiation-induced Esophageal Toxicity

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Phase+I-II

Page 1 of Clinical Trials for Phase I-II, 219 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About